Physician perspectives about the diagnosis and management of acute chest syndrome.
acute chest syndrome
sickle cell disease
transfusions
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
07 Oct 2024
07 Oct 2024
Historique:
revised:
17
09
2024
received:
20
06
2024
accepted:
18
09
2024
medline:
7
10
2024
pubmed:
7
10
2024
entrez:
7
10
2024
Statut:
aheadofprint
Résumé
Acute chest syndrome (ACS) is the leading cause of mortality, accounting for 25% of all deaths among individuals with sickle cell disease (SCD). There is a lack of evidence-based laboratory and clinical risk stratification guidelines for the diagnosis and management of ACS. To better understand physician practices for the management of ACS in the United States, we created an ACS Working Group including hematology and transfusion medicine physicians from four different SCD treatment centers in the United States. The working group created a physician survey that included physician demographics and ACS diagnostic criteria that they had to rate. The survey also included three case scenarios to assess physician attitudes about the management of ACS. Management options included supportive and preventive strategies in addition to transfusion therapy options. Out of 455 physicians who received the survey, 195 responded (response rate = 43%). The respondents were primarily hematology/oncology physicians. The responses showed wide variability among physicians in how diagnostic criteria for ACS are used and how physicians risk-stratify ACS patients in their practice. The responses also reflected variability in the use of transfusions for ACS. Based on our results, we conclude that ACS is diagnosed and managed inconsistently among expert physicians, especially in their transfusion practices due to a lack of consensus on risk stratification criteria. Our data suggest an urgent need for well-designed prospective studies to provide evidence-based guidelines and minimize management variability among physicians who care for individuals with SCD and ACS.
Sections du résumé
BACKGROUND
BACKGROUND
Acute chest syndrome (ACS) is the leading cause of mortality, accounting for 25% of all deaths among individuals with sickle cell disease (SCD). There is a lack of evidence-based laboratory and clinical risk stratification guidelines for the diagnosis and management of ACS.
STUDY DESIGN AND METHODS
METHODS
To better understand physician practices for the management of ACS in the United States, we created an ACS Working Group including hematology and transfusion medicine physicians from four different SCD treatment centers in the United States. The working group created a physician survey that included physician demographics and ACS diagnostic criteria that they had to rate. The survey also included three case scenarios to assess physician attitudes about the management of ACS. Management options included supportive and preventive strategies in addition to transfusion therapy options.
RESULTS
RESULTS
Out of 455 physicians who received the survey, 195 responded (response rate = 43%). The respondents were primarily hematology/oncology physicians. The responses showed wide variability among physicians in how diagnostic criteria for ACS are used and how physicians risk-stratify ACS patients in their practice. The responses also reflected variability in the use of transfusions for ACS.
DISCUSSION
CONCLUSIONS
Based on our results, we conclude that ACS is diagnosed and managed inconsistently among expert physicians, especially in their transfusion practices due to a lack of consensus on risk stratification criteria. Our data suggest an urgent need for well-designed prospective studies to provide evidence-based guidelines and minimize management variability among physicians who care for individuals with SCD and ACS.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Transfusion published by Wiley Periodicals LLC on behalf of AABB.
Références
Alkindi S, Al‐Busaidi I, Al‐Salami B, Raniga S, Pathare A, Ballas SK. Predictors of impending acute chest syndrome in patients with sickle cell anaemia. Sci Rep. 2020;10(1):2470.
Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342(25):1855–1865.
Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512–S521.
Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006;108(9):2923–2927.
Howard J, Hart N, Roberts‐Harewood M, Cummins M, Awogbade M, Davis B, et al. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015;169(4):492–505.
Powars D, Weidman JA, Odom‐Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore). 1988;67(1):66–76.
Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood. 1995;86(2):776–783.
Sysol JRMR. Sickle cell disease and acute chest syndrome: epidemiology, diagnosis, Managment, outcomes. Hematologic Abnormalities Acute Lung Syndromes. 2017;67–87.
Allareddy V, Roy A, Lee MK, Nalliah RP, Rampa S, Allareddy V, et al. Outcomes of acute chest syndrome in adult patients with sickle cell disease: predictors of mortality. PLoS One. 2014;9(4):e94387.
Chaturvedi S, Ghafuri DL, Glassberg J, Kassim AA, Rodeghier M, DeBaun MR. Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype. Am J Hematol. 2016;91(12):1185–1190.
Bhasin N, Sarode R. Acute chest syndrome in sickle cell disease. Transfus Med Rev. 2023;37(3):150755.
Klings ES, Steinberg MH. Acute chest syndrome of sickle cell disease: genetics, risk factors, prognosis, and management. Expert Rev Hematol. 2022;15(2):117–125.
Miller AC, Gladwin MT. Pulmonary complications of sickle cell disease. Am J Respir Crit Care Med. 2012;185(11):1154–1165.
Hassell TWK. Best practices for transfusion for patients with sickle cell disease. Hematol Rev. 2009;1(2):106–110.
Sisler I, McClish DK, Valrie C, Villella A, Smith WR. Satisfaction and access to care for adults and adolescents with sickle cell disease: ASCQ‐me quality of care and the SHIP‐HU study. Pediatr Blood Cancer. 2022;69(12):e29948.
Velasquez MP, Mariscalco MM, Goldstein SL, Airewele GE. Erythrocytapheresis in children with sickle cell disease and acute chest syndrome. Pediatr Blood Cancer. 2009;53(6):1060–1063.
Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol. 2001;38(1 Suppl 1):14–22.
Howard J. Sickle cell disease: when and how to transfuse. Hematology Am Soc Hematol Educ Program. 2016;2016(1):625–631.
Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020;4(2):327–355.
Davis BA, Allard S, Qureshi A, Porter JB, Pancham S, Win N, et al. Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects. Br J Haematol. 2017;176(2):179–191.
Davis BA, Allard S, Qureshi A, Porter JB, Pancham S, Win N, et al. Guidelines on red cell transfusion in sickle cell disease part II: indications for transfusion. Br J Haematol. 2017;176(2):192–209.
Tsitsikas DA, Badle S, Hall R, Meenan J, Bello‐Sanyaolu O, Orebayo F, et al. Automated red cell exchange in the Management of Sickle Cell Disease. J Clin Med. 2021;10(4):1–13.
Swerdlow PS. Red cell exchange in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2006;48–53.
Biller E, Zhao Y, Berg M, Boggio L, Capocelli KE, Fang DC, et al. Red blood cell exchange in patients with sickle cell disease‐indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB. Transfusion. 2018;58(8):1965–1972.
Goldstein SL. Therapeutic apheresis in children: special considerations. Semin Dial. 2012;25(2):165–170.
Jeng MR, Feusner J, Skibola C, Vichinsky E. Central venous catheter complications in sickle cell disease. Am J Hematol. 2002;69(2):103–108.
Yeral M, Boga C, Oguzkurt L, Asma S, Kasar M, Kozanoglu I. Short‐term central venous catheter complications in patients with sickle cell disease who undergo apheresis. J Thromb Thrombolysis. 2014;37(2):97–101.
Alkindi S, Matwani S, Al‐Maawali A, Al‐Maskari B, Pathare A. Complications of PORT‐A‐CATH(R) in patients with sickle cell disease. J Infect Public Health. 2012;5(1):57–62.
Fatihoglu E, Aydin S, Gokharman FD, Ece B, Kosar PN. X‐ray use in chest imaging in emergency department on the basis of cost and effectiveness. Acad Radiol. 2016;23(10):1239–1245.
Dunbar LN, Coleman Brown L, Rivera DR, Hartzema AG, Lottenberg R. Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists. ISRN Hematol 2012;2012:524513.
Mekontso Dessap A, Deux JF, Habibi A, Abidi N, Godeau B, Adnot S, et al. Lung imaging during acute chest syndrome in sickle cell disease: computed tomography patterns and diagnostic accuracy of bedside chest radiograph. Thorax. 2014;69(2):144–151.
Cho Y, Kim YG, Lee SM, Seo JB, Kim N. Reproducibility of abnormality detection on chest radiographs using convolutional neural network in paired radiographs obtained within a short‐term interval. Sci Rep. 2020;10(1):17417.
Taghizadieh A, Ala A, Rahmani F, Nadi A. Diagnostic accuracy of chest x‐ray and Ultrasonography in detection of community acquired pneumonia; a brief report. Emerg (Tehran). 2015;3(3):114–116.
Okomo U, Meremikwu MM. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst Rev. 2017;7(7):CD005406.
Haynes J Jr, Allison RC. Pulmonary edema. Complication in the management of sickle cell pain crisis. Am J Med. 1986;80(5):833–840.
Hash RB, Stephens JL, Laurens MB, Vogel RL. The relationship between volume status, hydration, and radiographic findings in the diagnosis of community‐acquired pneumonia. J Fam Pract. 2000;49(9):833–837.